Details of the Drug

General Information of Drug (ID: DM5SSPZ)

Drug Name
isaralgagene civaparvovec
Synonyms ST-920
Indication
Disease Entry ICD 11 Status REF
Fabry disease 5C56.01 Phase 1/2 [1]
Drug Type
Gene therapy
Cross-matching ID
TTD ID
DX5HW2

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Alpha-galactosidase A (GLA) TTIS03D AGAL_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04046224) A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease (STAAR). U.S.National Institutes of Health.